Recent Updates
Recently added Catalysts
MAZE

NOVEMBER 2023 | MAZE THERAPEUTICS

Key Takeaway: The article provides an overview of the cookie policy for the Maze Therapeutics website. It details the use of essential cookies for website functionality and analytics. The content emphasizes user experience and the importance of cookies in recognizing returning visitors and measuring website performance.

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+9%
120-day peak, hindsight
Typical move
1.8%
average across 3 past catalysts
Cash runway
~31 mo
Minimal dilution risk
Lead asset
MZE829
Phase 2 · Proteinuric Kidney Disease

Full Press Release Details

• Privacy Overview
• Essential Cookies
• 3rd Party Cookies
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
These cookies are necessary for our website to function and for measurement purposes. Opt-out rights do not apply to these cookies.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.

Frequently Asked Questions

What cookies does Maze Therapeutics use?

Maze Therapeutics uses essential cookies for website functionality and analytics.

How does Maze Therapeutics improve user experience?

The website uses cookies to recognize returning visitors and enhance user experience.

Can I opt-out of cookies on Maze's website?

Opt-out rights do not apply to essential cookies used on Maze Therapeutics' website.

What is the purpose of Google Analytics on the site?

Google Analytics collects anonymous data on visitor numbers and popular pages.

Last updated: Nov 13, 2023